Agonist redirected checkpoint, PD1-Fc-OX40L, for cancer immunotherapy

Simultaneous blockade of immune checkpoint molecules and co-stimulation of the TNF receptor superfamily (TNFRSF) is predicted to improve overall survival in human cancer. TNFRSF co-stimulation depends upon coordinated antigen recognition through the T cell receptor followed by homotrimerization of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Fromm, George, de Silva, Suresh, Johannes, Kellsey, Patel, Arpita, Hornblower, Josiah C., Schreiber, Taylor H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299665/
https://www.ncbi.nlm.nih.gov/pubmed/30563566
http://dx.doi.org/10.1186/s40425-018-0454-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299665/
https://www.ncbi.nlm.nih.gov/pubmed/30563566
http://dx.doi.org/10.1186/s40425-018-0454-3

Ejemplares similares